Teva Launches Generic Seroquel on First Day of Patent Loss (TEVA, AZN)
We noted earlier today that AstraZeneca plc (NYSE: AZN) had lost a patent ruling and that the company’s anti-pyschotic drug Seroquel lost its patent protection today. That’s all it took ...Read Full Story »

